[ACRV] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -3.97%
YoY- -64.00%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 1,884 0 0 0 0 -
PBT -18,798 -16,486 -19,252 -14,466 -13,914 -12,756 -8,929 64.33%
Tax 0 181 1,770 -133 7 -1,637 -1,016 -
NP -18,798 -16,486 -19,252 -14,466 -13,914 -11,119 -7,913 78.13%
Tax Rate - - - - - - - -
Total Cost 18,798 16,486 21,136 14,466 13,914 11,119 7,913 78.13%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -1,021.87 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.52 -0.73 -0.86 -0.66 -0.63 -0.51 -0.38 23.28%
EPS Diluted -0.52 -0.73 -0.86 -0.66 -0.63 -0.51 -0.38 23.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.